1 / 7

Biologics Market Demand, Cost Structures To 2019- 2026

The study segments the Biologics industry in light of major classification such as product type, potential markets, application, and end-user.

RayMarchant
Download Presentation

Biologics Market Demand, Cost Structures To 2019- 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biologics Market To Reach USD 625.6 Million By 2026

  2. Market Summary Rise in prevalence of target chronic diseases like cancer, increase in unhealthy lifestyle habits, mergers and acquisitions by major companies, product launches, the development of biologics with higher efficiency and favorable research funding scenario are key factors contributing to high CAGR of Biologics during forecast period. Market Size – USD 251.5 million in 2018, Market Growth - CAGR of 11.9%, Market Trends – Product launches and research for advanced biologics. According to the current analysis of Reports and Data, the global Biologics market was valued at USD 251.5 million in 2018 and is expected to reach USD 625.6 million by the year 2026, at a CAGR of 11.9%. The study covers Biologics, a drug that contains living organisms or their specific components or by-products. Biologic medicines are usually injected into the patient’s body because of its large molecular size (200-1000x) and fragile molecular structure. Parts of organisms like their cells, tissues, recombinant proteins, genes, allergens, blood or blood components, and vaccines are used in biologic drugs. Biologics are used for the treatment of various diseases and conditions like anemia, cancer, and other autoimmune diseases. Biologics are changing the ways doctors treat common conditions that have plagued individuals for years. . Biologics have various potential advantages as they can, theoretically, be customized to hit specific ‘gene targets’ in the human body www.reportsanddata.com

  3. Further key findings from the report suggest • Biologics market is growing at a CAGR of 13.0% in Asia Pacific followed by North America and Europe, with 11.8% and 11.6% CAGR, respectively. Rise in prevalence of cancer and other target diseases across the globe is the key factor to accelerate the market growth during forecast period across all regions. • As of 2018, Monoclonal Antibodies segment dominates the market holding 39.0% of the global market since it is the primary medicine used for the treatment of cancer. • On the basis of product type, Gene biologics are growing predominantly with a CAGR of 14.3% followed by vaccines and cellular biologics. • On the basis of application, Cancer is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 12.4%.The key factor responsible for the growth of the segment is predominant rise in cancer and geriatric population worldwide. • Cancer application segment holds a market share of 42.2% followed by autoimmune diseases and infectious diseases holding 35.9% and 14.6% respectively. • Asia Pacific is expected to account for the 21.4% of the global Biologics market due to the large prevalence of target diseases in countries like India and China. • Stringent government regulations and associated side effects like gastrointestinal complications, change in blood pressure, chest pain, breathing problems etc. are the key challenges faced by the Biologics market players.

  4. Market Summary Key Players: Merck & Co. Inc., AbbVie, Inc., AstraZeneca Plc., Amgen, Inc., Celgene Corporation, Bristol-Myers Squibb Co., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., GlaxoSmithKline Plc., Novartis AG, Pfizer, Inc., and Novo Nordisk A/S. Segmentation: For the purpose of this report, Reports and Data has segmented the Biologics market on the basis of product, application, end use and region: Product type Outlook (Revenue, USD Million; 2016-2026) •Monoclonal Antibodies •Vaccines •Recombinant Hormones/Proteins •Cellular Based Biologics •Gene Based Biologics Application Outlook (Revenue, USD Million; 2016-2026) •Cancer •Infectious Diseases •Autoimmune diseases •Others To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://www.reportsanddata.com/sample-enquiry-form/2030 www.reportsanddata.com

  5. Market Summary End use Outlook (Revenue, USD Million; 2016-2026) •Hospitals •Clinics •Diagnostic Centers •Others Regional Outlook (Revenue, USD Million; 2016-2026) •North America •Europe •Asia Pacific •Middle East & Africa •Latin America Grab Your Report at an Impressive Discount! Please Click Here : https://www.reportsanddata.com/make-enquiry-form/2030 www.reportsanddata.com

  6. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  7. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related